{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T03:21:29Z","timestamp":1788405689747,"version":"build-2803163510"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":31,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journalofnuclearcardiology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.nuclcard.2026.102726","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:03:42Z","timestamp":1778846622000},"page":"102726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S","title":["An era of precision: Emerging, research, and adjunct radiotracers for nuclear imaging of cardiac amyloidosis"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5516-8578","authenticated-orcid":false,"given":"Jonathan S.","family":"Wall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4993-5782","authenticated-orcid":false,"given":"Emily B.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nuclcard.2026.102726_bib1","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-Evidence base and standardized methods of imaging","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib2","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 2 of 2-Diagnostic criteria and appropriate utilization","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/ehjci\/jeae295","article-title":"Prognostic implication of DPD quantification in transthyretin cardiac amyloidosis","volume":"26","author":"Rettl","year":"2025","journal-title":"Eur Heart J Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13506129.2021.1991302","article-title":"The role of serial (99m)Tc-DPD scintigraphy in monitoring cardiac transthyretin amyloidosis","volume":"29","author":"Ross","year":"2022","journal-title":"Amyloid"},{"key":"10.1016\/j.nuclcard.2026.102726_bib5","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/ehjci\/jead030","article-title":"Monitoring tafamidis treatment with quantitative SPECT\/CT in transthyretin amyloid cardiomyopathy","volume":"24","author":"Rettl","year":"2023","journal-title":"Eur Heart J Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10741-025-10493-3","article-title":"Positron emission tomography in cardiac amyloidosis: current evidence and future directions","volume":"30","author":"Aimo","year":"2025","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.nuclcard.2026.102726_bib7","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.hfc.2024.09.006","article-title":"PET and cardiac amyloidosis: which possible role?","volume":"20","author":"Aimo","year":"2024","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.nuclcard.2026.102726_bib8","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1053\/j.semnuclmed.2024.05.012","article-title":"Radionuclide imaging of cardiac amyloidosis: an update and future aspects","volume":"54","author":"Clerc","year":"2024","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib9","doi-asserted-by":"crossref","first-page":"20S","DOI":"10.2967\/jnumed.122.264866","article-title":"Molecular imaging of systemic and cardiac amyloidosis: recent advances and focus on the future","volume":"64","author":"Dorbala","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s44303-025-00124-9","article-title":"Beyond perfusion: a review of peptide radiopharmaceuticals for cardiovascular imaging","volume":"3","author":"Krol","year":"2025","journal-title":"Npj Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jcmg.2025.03.011","article-title":"Established and emerging Fluorine-18-Labeled cardiac PET radiotracers","volume":"18","author":"Packard","year":"2025","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib12","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1182\/blood.2024026386","article-title":"Visualizing amyloidosis: the role of radionuclide imaging in systemic amyloidosis","volume":"146","author":"Ranjit Anderson","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.nuclcard.2026.102726_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2025.106562","article-title":"Multimodality imaging for cardiac amyloidosis: clinical applications and future directions","volume":"144","author":"Sinigiani","year":"2026","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib14","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221082","article-title":"(99m)Tc bone-avid tracer cardiac scintigraphy: role in noninvasive diagnosis of transthyretin cardiac amyloidosis","volume":"306","author":"Khor","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.nuclcard.2026.102726_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.hfc.2025.01.009","article-title":"Current status of radionuclide imaging of transthyretin cardiac amyloidosis","volume":"21","author":"Waheed","year":"2025","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.nuclcard.2026.102726_bib16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/10409238.2021.1937926","article-title":"The amyloid proteome: a systematic review and proposal of a protein classification system","volume":"56","author":"Gottwald","year":"2021","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24031921","article-title":"Microcalcification and (99m)Tc-Pyrophosphate uptake without increased bone metabolism in cardiac tissue from patients with transthyretin cardiac amyloidosis","volume":"24","author":"Mori","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nuclcard.2026.102726_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2022.01.036","article-title":"Cardiac microcalcifications in transthyretin (ATTR) amyloidosis","volume":"352","author":"Thelander","year":"2022","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib19","article-title":"Artificial intelligence-driven longitudinal quantification of technetium pyrophosphate uptake in cardiac amyloidosis: correlation with multimodality imaging and outcomes","author":"Miller","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102019","article-title":"Quantitative (99m)Tc-pyrophosphate myocardial uptake: changes on transthyretin stabilization therapy","volume":"39","author":"Vijayakumar","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib21","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s12350-023-03316-1","article-title":"A case of disappearing amyloid on technetium pyrophosphate scan","volume":"30","author":"Wang","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib22","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/ehjci\/jeab095","article-title":"99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis","volume":"22","author":"Quarta","year":"2021","journal-title":"Eur Heart J Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.121.012506","article-title":"Cardiac magnetic resonance-derived extracellular volume mapping for the quantification of hepatic and splenic amyloid","volume":"14","author":"Chacko","year":"2021","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib24","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199008233230803","article-title":"Evaluation of systemic amyloidosis by scintigraphy with 123I-labeled serum amyloid P component","volume":"323","author":"Hawkins","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib25","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF01254559","article-title":"Imaging amyloidosis with radiolabelled SAP","volume":"22","author":"Hawkins","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib26","doi-asserted-by":"crossref","first-page":"7657","DOI":"10.3390\/molecules20057657","article-title":"Preclinical validation of the heparin-reactive peptide p5+14 as a molecular imaging agent for visceral amyloidosis","volume":"20","author":"Wall","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.nuclcard.2026.102726_bib27","doi-asserted-by":"crossref","first-page":"E586","DOI":"10.1073\/pnas.1103247108","article-title":"In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides","volume":"108","author":"Wall","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.nuclcard.2026.102726_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/ph18091340","article-title":"Pan-amyloid reactive peptides p5+14 and p5R exhibit specific charge-dependent binding to glycosaminoglycans","volume":"18","author":"Hancock","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.nuclcard.2026.102726_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ph16040629","article-title":"Clinical confirmation of pan-amyloid reactivity of radioiodinated peptide (124)I-p5+14 (AT-01) in patients with diverse types of systemic amyloidosis demonstrated by PET\/CT imaging","volume":"16","author":"Martin","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.nuclcard.2026.102726_bib30","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1182\/blood-2023-189599","article-title":"Early development and pre-clinical evaluation of a Fluorine-18 labeled peptide p5+14 for PET\/CT imaging of cardiac amyloidosis","volume":"142","author":"Webster","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.nuclcard.2026.102726_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11307-021-01681-2","article-title":"First in human evaluation and dosimetry calculations for peptide (124)I-p5+14-a novel radiotracer for the detection of systemic amyloidosis using PET\/CT imaging","volume":"24","author":"Wall","year":"2022","journal-title":"Mol Imag Biol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib32","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jcmg.2023.08.009","article-title":"Cardiac amyloid detection by PET\/CT imaging of iodine ((124)I) evuzamitide ((124)I-p5+14): a phase 1\/2 study","volume":"16","author":"Wall","year":"2023","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib33","first-page":"1","article-title":"Longitudinal PET\/CT imaging with iodine ((124)I) evuzamitide reveals organ response to plasma cell immunotherapy in a patient with AL amyloidosis","author":"Lands","year":"2023","journal-title":"Amyloid"},{"key":"10.1016\/j.nuclcard.2026.102726_bib34","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0735-1097(25)01667-5","article-title":"Diagnostic performance of cardiac and whole-body 124I-evuzamitide (AT-01) PET\/MRI in systemic amyloidosis","volume":"85","author":"Masri","year":"2025","journal-title":"JACC"},{"key":"10.1016\/j.nuclcard.2026.102726_bib35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac amyloid quantification using (124)I-Evuzamitide ((124)I-P5+14) versus (18)F-Florbetapir: a pilot PET\/CT study","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib36","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s12350-023-03267-7","article-title":"In the thick of it: hereditary cardiac amyloidosis identified by (124)I-AT-01 PET imaging but not cardiac MRI or SPECT (99m)Tc pyrophosphate scintigraphy","volume":"30","author":"Smiley","year":"2023","journal-title":"J Nucl Cardiol"},{"issue":"7","key":"10.1016\/j.nuclcard.2026.102726_bib37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jcmg.2025.01.018","article-title":"Early detection of transthyretin cardiac amyloidosis using (124)I-Evuzamitide positron emission tomography\/computed tomography","volume":"18","author":"Smiley","year":"2025","journal-title":"J Am Coll Cardiol Img"},{"key":"10.1016\/j.nuclcard.2026.102726_bib38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40336-015-0102-6","article-title":"Beta-amyloid imaging with florbetaben","volume":"3","author":"Sabri","year":"2015","journal-title":"Clin Transl Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2019.106281","article-title":"Computational investigation of the binding characteristics of beta-amyloid fibrils","volume":"256","author":"Marondedze","year":"2020","journal-title":"Biophys Chem"},{"key":"10.1016\/j.nuclcard.2026.102726_bib40","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1016\/j.bmc.2010.06.044","article-title":"Synthesis and evaluation of stilbene derivatives as a potential imaging agent of amyloid plaques","volume":"18","author":"Hong","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.nuclcard.2026.102726_bib41","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.nucmedbio.2005.06.001","article-title":"F-18 polyethyleneglycol stilbenes as PET imaging agents targeting abeta aggregates in the brain","volume":"32","author":"Zhang","year":"2005","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib42","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s11886-022-01811-4","article-title":"Radiolabeled Thioflavin-T derivative PET imaging for the assessment of cardiac amyloidosis","volume":"24","author":"Boczar","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.nuclcard.2026.102726_bib43","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2967\/jnumed.115.169870","article-title":"Cardiac amyloid imaging with 18F-Florbetaben PET: a pilot study","volume":"57","author":"Law","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib44","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with (18)F-Florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy","volume":"46","author":"Kircher","year":"2019","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib45","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1007\/s00259-020-04861-4","article-title":"(18)F-florbetaben positron emission tomography detects cardiac involvement in systemic AA amyloidosis","volume":"47","author":"Papathanasiou","year":"2020","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcmg.2020.05.031","article-title":"[18F]-Florbetaben PET\/CT for differential diagnosis among cardiac immunoglobulin light chain, transthyretin amyloidosis, and mimicking conditions","volume":"14","author":"Genovesi","year":"2021","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib47","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13550-018-0425-1","article-title":"(18)F-florbetaben whole-body PET\/MRI for evaluation of systemic amyloid deposition","volume":"8","author":"Baratto","year":"2018","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nuclcard.2026.102726_bib48","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1182\/blood-2023-186377","article-title":"Serial 18F-Florbetaben positron emission tomography and cardiac magnetic resonance imaging in the evaluation of systemic light chain cardiac amyloidosis enhances diagnostic and response assessment accuracy","volume":"142","author":"Anderson","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.nuclcard.2026.102726_bib49","article-title":"A tale of two tracers - amyloid imaging with investigational radiotracers iodine ((124)I) evuzamitide and (99m)Tc-p5+14 (AT-05)","author":"Martin","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301756","article-title":"Preclinical evaluation of Tc-99m p5+14 peptide for SPECT detection of cardiac amyloidosis","volume":"19","author":"Kennel","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.nuclcard.2026.102726_bib51","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11307-015-0914-9","article-title":"Tc-99m radiolabeled peptide p5 + 14 is an effective probe for SPECT imaging of systemic amyloidosis","volume":"18","author":"Kennel","year":"2016","journal-title":"Mol Imag Biol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib52","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0735-1097(24)03359-X","article-title":"Detection of amyloid cardiomyopathy in patients with systemic ATTR and AL amyloidosis using SPECT\/CT and planar imaging of a Technetium-99m-Labeled peptide - technetium-99m (99mTc) evuzamitide","volume":"83","author":"Wall","year":"2024","journal-title":"JACC"},{"key":"10.1016\/j.nuclcard.2026.102726_bib53","article-title":"Preliminary evaluation of 99mTc-Labeled peptide p5+14 for the detection of cardiopulmonary amyloidosis using SPECT\/CT and planar gamma scintigraphic imaging","volume":"65","author":"Wall","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jlcr.3381","article-title":"(99m)Tc-aprotinin - optimisation and validation of radiolabelling kits for routine preparation for diagnostic imaging of amyloidosis","volume":"59","author":"Denholt","year":"2016","journal-title":"J Label Compd Radiopharm"},{"key":"10.1016\/j.nuclcard.2026.102726_bib55","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1046\/j.1432-1327.2000.01237.x","article-title":"Aprotinin binding to amyloid fibrils","volume":"267","author":"Cardoso","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.nuclcard.2026.102726_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10061377","article-title":"A narrative review of (99m)Tc-Aprotinin in the diagnosis of cardiac amyloidosis and a new life for an unfairly abandoned drug","volume":"10","author":"Aprile","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.nuclcard.2026.102726_bib57","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/BF01791147","article-title":"Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin","volume":"22","author":"Aprile","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib58","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1600-0609.2007.00963.x","article-title":"Preliminary experience of 99mTc-Aprotinin scintigraphy in amyloidosis","volume":"79","author":"Han","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib59","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s12350-019-01868-9","article-title":"Performance of (99m)Tc-aprotinin scintigraphy for diagnosing light chain (AL) cardiac amyloidosis confirmed by endomyocardial biopsy","volume":"27","author":"Awaya","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib60","first-page":"177","article-title":"99mTc-Aprotinin scintigraphy in amyloidosis","volume":"44","author":"Schaadt","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib61","first-page":"787","article-title":"[Transluminal internal mammary artery angioplasty using the brachial approach: a case report]","volume":"35","author":"Takashiba","year":"1987","journal-title":"Kokyu To Junkan"},{"key":"10.1016\/j.nuclcard.2026.102726_bib62","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa0802395","article-title":"A comparison of aprotinin and lysine analogues in high-risk cardiac surgery","volume":"358","author":"Fergusson","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib63","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/biomedicines10061377","article-title":"A narrative review of 99mTc-Aprotinin in the diagnosis of cardiac amyloidosis and a new life for an unfairly abandoned drug","volume":"10","author":"Aprile","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.nuclcard.2026.102726_bib64","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/jacs.1c12056","article-title":"Binding sites of a positron emission tomography imaging agent in Alzheimer's beta-amyloid fibrils studied using (19)F solid-state NMR","volume":"144","author":"Duan","year":"2022","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nuclcard.2026.102726_bib65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2967\/jnumed.111.102053","article-title":"In vivo visualization of amyloid deposits in the heart with 11C-PIB and PET","volume":"54","author":"Antoni","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib66","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jcmg.2020.02.023","article-title":"Diagnostic accuracy of [(11)C]PIB positron emission tomography for detection of cardiac amyloidosis","volume":"13","author":"Rosengren","year":"2020","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101816","article-title":"Feasibility of PiB positron emission tomography\/computed tomography for treatment monitoring with tafamidis in a patient with transthyretin cardiac amyloidosis","volume":"33","author":"Fujioka","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib68","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jacc.2019.11.037","article-title":"Pittsburgh B compound positron emission tomography in patients with AL cardiac amyloidosis","volume":"75","author":"Lee","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib69","doi-asserted-by":"crossref","DOI":"10.31083\/RCM37731","article-title":"Diagnostic performance of positron emission tomography in the assessment of systemic amyloidosis: a systematic review and meta-analysis","volume":"26","author":"Zhu","year":"2025","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2026.1747625","article-title":"Pittsburgh compound B positron emission tomography detects cardiomyopathy in hereditary transthyretin amyloidosis patients with negative bone scintigraphy: a pilot study","volume":"6","author":"Tingen","year":"2026","journal-title":"Front Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib71","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: a pilot study using (1)(8)F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib72","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/ehjci\/jead350","article-title":"Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography\/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosis","volume":"25","author":"Datar","year":"2024","journal-title":"Eur Heart J Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib73","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jcmg.2024.05.002","article-title":"Prognostic value of left ventricular (18)F-Florbetapir uptake in systemic light-chain amyloidosis","volume":"17","author":"Clerc","year":"2024","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib74","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jcmg.2025.07.017","article-title":"Changes in myocardial light chain amyloid burden after plasma cell therapy","volume":"18","author":"Benz","year":"2025","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fcvm.2015.00023","article-title":"A routine PET\/CT protocol with streamlined calculations for assessing cardiac amyloidosis using (18)F-Florbetapir","volume":"2","author":"Osborne","year":"2015","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib76","article-title":"Kinetic analysis of cardiac dynamic (18)F-Florbetapir PET in healthy volunteers and amyloidosis patients: a pilot study","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.nuclcard.2026.102726_bib77","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00259-018-3995-2","article-title":"Extracardiac (18)F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds","volume":"45","author":"Wagner","year":"2018","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib78","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2967\/jnumed.118.221770","article-title":"Early detection of multiorgan light-chain amyloidosis by whole-body (18)F-Florbetapir PET\/CT","volume":"60","author":"Ehman","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib79","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/RLU.0000000000000492","article-title":"Is 18F-flutemetamol PET\/CT able to reveal cardiac amyloidosis?","volume":"39","author":"Lhommel","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib80","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s12350-020-02363-2","article-title":"(18)F-flutemetamol positron emission tomography in cardiac amyloidosis","volume":"29","author":"Papathanasiou","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/13506129.2020.1760237","article-title":"Quantification of cardiac amyloid with [(18)F]Flutemetamol in patients with V30M hereditary transthyretin amyloidosis","volume":"27","author":"Mockelind","year":"2020","journal-title":"Amyloid"},{"key":"10.1016\/j.nuclcard.2026.102726_bib82","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1021\/acs.jmedchem.2c01503","article-title":"Fluorine-18-Labeled diaryl-azines as improved beta-amyloid imaging tracers: from bench to first-in-human studies","volume":"66","author":"Li","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.nuclcard.2026.102726_bib83","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1007\/s00259-025-07719-9","article-title":"Preclinical and preliminary clinical evaluation of [(18)F]Florbetazine for non-invasive PET detection of cardiac amyloidosis","volume":"53","author":"Li","year":"2026","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nuclcard.2026.102726_bib84","doi-asserted-by":"crossref","first-page":"6823","DOI":"10.1016\/j.acra.2025.07.034","article-title":"Beyond cancer: the role of radiolabeled fibroblast activation protein inhibitors (FAPI) in non-oncological molecular imaging","volume":"32","author":"Jafari","year":"2025","journal-title":"Acad Radiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib85","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1016\/j.jcmg.2022.06.004","article-title":"Feasibility of (68)Ga-Labeled fibroblast activation protein inhibitor PET\/CT in light-chain cardiac amyloidosis","volume":"15","author":"Wang","year":"2022","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib86","doi-asserted-by":"crossref","first-page":"e476","DOI":"10.1097\/RLU.0000000000005380","article-title":"99mTc-PYP and 68Ga-FAPI PET\/CT images of hereditary transthyretin amyloidosis with cardiac involvement","volume":"49","author":"Kibar","year":"2024","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib87","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1152\/jn.1990.64.4.1319","article-title":"Neural mechanisms underlying the clasp-knife reflex in the cat. II. Stretch-sensitive muscular-free nerve endings","volume":"64","author":"Cleland","year":"1990","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib88","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/art.1780311114","article-title":"A retrospective study of antibodies against basement membrane antigens (type IV collagen and laminin) in patients with primary and secondary Raynaud's phenomenon","volume":"31","author":"Gabrielli","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.nuclcard.2026.102726_bib89","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1007\/s00259-018-3963-x","article-title":"Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers","volume":"45","author":"Piekarski","year":"2018","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib90","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12350-017-1059-9","article-title":"Imaging cardiac innervation in amyloidosis","volume":"26","author":"Slart","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib91","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jcmg.2024.11.003","article-title":"Development of imaging endpoints for clinical trials in AL and ATTR amyloidosis: proceedings of the amyloidosis forum","volume":"18","author":"Dorbala","year":"2025","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib92","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMp1208061","article-title":"Brain amyloid imaging--FDA approval of florbetapir F18 injection","volume":"367","author":"Yang","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib93","first-page":"177","article-title":"99mTc-aprotinin scintigraphy in amyloidosis","volume":"44","author":"Schaadt","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2026.102726_bib94","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1358\/dot.2013.49.3.1937428","article-title":"Florbetapir F 18 for brain imaging of beta-amyloid plaques","volume":"49","author":"Romano","year":"2013","journal-title":"Drugs Today"},{"key":"10.1016\/j.nuclcard.2026.102726_bib95","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00259-015-3208-1","article-title":"Imaging beta-amyloid using [(18)f]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis","volume":"43","author":"Heurling","year":"2016","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib96","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002954","article-title":"18F-Florbetapir binds specifically to myocardial light chain and transthyretin amyloid deposits: autoradiography study","volume":"8","author":"Park","year":"2015","journal-title":"Circ Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib97","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/13506129.2018.1552852","article-title":"A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement","volume":"25","author":"Manwani","year":"2018","journal-title":"Amyloid"},{"key":"10.1016\/j.nuclcard.2026.102726_bib98","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jcmg.2025.01.018","article-title":"Early detection of transthyretin cardiac amyloidosis using (124)I-Evuzamitide positron emission tomography\/computed tomography","volume":"18","author":"Smiley","year":"2025","journal-title":"JACC Cardiovasc Imag"},{"key":"10.1016\/j.nuclcard.2026.102726_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102733","article-title":"Advancements and challenges in cardiac amyloidosis imaging: a comprehensive review of novel techniques and clinical applications","volume":"49","author":"Albulushi","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.nuclcard.2026.102726_bib100","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1093\/ehjci\/jeae332","article-title":"Estimated total amyloid burden from 18F-florbetaben positron emission tomography predicts all-cause mortality in light-chain cardiac amyloidosis","volume":"26","author":"Vergaro","year":"2025","journal-title":"Eur Heart J Cardiovasc Imag"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358126001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358126001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T06:42:39Z","timestamp":1784702559000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358126001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":100,"alternative-id":["S1071358126001078"],"URL":"https:\/\/doi.org\/10.1016\/j.nuclcard.2026.102726","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An era of precision: Emerging, research, and adjunct radiotracers for nuclear imaging of cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2026.102726","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society of Nuclear Cardiology.","name":"copyright","label":"Copyright"}],"article-number":"102726"}}